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Dopaminergic signaling and plasticity are essential to numerous CNS functions and pathologies, including movement, cognition, and
addiction. The amphetamine- and cocaine-sensitive dopamine (DA) transporter (DAT) tightly controls extracellular DA concentrations
and half-life. DAT function and surface expression are not static but are dynamically modulated by membrane trafficking. We recently
demonstrated that the DAT C terminus encodes a PKC-sensitive internalization signal that also suppresses basal DAT endocytosis.
However, the cellular machinery governing regulated DAT trafficking is not well defined. In work presented here, we identified the
Ras-like GTPase, Rin (for Ras-like in neurons) (Rit2), as a protein that interacts with the DAT C-terminal endocytic signal. Yeast
two-hybrid, GSTpull down andFRET studies establish thatDAT andRin directly interact, and colocalization studies reveal thatDAT/Rin
associations occur primarily in lipid raft microdomains. Coimmunoprecipitations demonstrate that PKC activation regulates Rin asso-
ciationwithDAT. Perturbation of Rin functionwith GTPasemutants and shRNA-mediatedRin knockdown reveals that Rin is critical for
PKC-mediated DAT internalization and functional downregulation. These results establish that Rin is a DAT-interacting protein that is
required for PKC-regulated DAT trafficking. Moreover, this work suggests that Rin participates in regulated endocytosis.
Introduction
Presynaptic neurotransmitter reuptake facilitated by plasma
membrane transporters is the primary mechanism terminating
synaptic transmission. Dopamine transporter (DAT) terminates
DA signaling and thus is central to controlling extracellular DA
levels in the brain (Torres and Amara, 2007). DAT is the primary
target for therapeutic agents such as methylphenidate (Ritalin)
and bupropion (Wellbutrin), as well as the addictive psycho-
stimulants amphetamine and cocaine, whose actions inhibit
DAT function (Iversen, 2006). Recent knock-in transgenic
mouse studies demonstrated that DAT availability is paramount
to establishing the rewarding properties of cocaine (Chen et al.,
2006), and aberrant DAT function was reported recently in a
subgroup of attention-deficit hyperactivity disorder (ADHD)
patients (Mazei-Robison et al., 2008). Moreover, DAT/ and
DAT/ mice are hyperlocomotive and exhibit significant DA
depletion in tissue stores (Gainetdinov et al., 1998; Jones et al.,
1998). Thus, mechanisms that regulate DAT plasma membrane
availability are likely to have a significant impact onDA signaling
and the availability of DAT to interact with therapeutic and ad-
dictive drugs.
A wealth of data demonstrates that DAT activity is acutely
downregulated by protein kinase C (PKC) activation, resulting in
DAT trafficking to, and sequestering in, endosomal vesicles (Tor-
res et al., 2003;Melikian, 2004).Work from our laboratory estab-
lished that DAT C-terminal residues 587–596 encode endocytic
regulatory domain thatmodulates both basal and PKC-enhanced
DAT internalization rates (Holton et al., 2005; Boudanova et al.,
2008). The DAT N terminus is also central to regulating DAT
endocytic trafficking (Sorkina et al., 2009), and Nedd4–2-
mediated ubiquitination in this domain is critical for PKC-
mediated DAT sequestration (Sorkina et al., 2006;Miranda et al.,
2007). A variety of proteins have been identified that interactwith
DAT, including PICK1 (Torres et al., 2001; Bjerggaard et al.,
2004), Hic-5 (Carneiro et al., 2002), synaptogyrin-3 (Egan˜a et al.,
2009), and calcium/calmodulin-dependent kinase II (CaMKII)
(Fog et al., 2006). However, none of these identified DAT-
interacting proteins are mechanistically linked to PKC-regulated
DAT internalization. In the current study, we sought to identify
proteins that (1) interacted with DAT endocytic regulatory resi-
dues 587–596 and (2) were required for PKC-regulated DAT
trafficking. A yeast two-hybrid screen identified the Rin (for
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Ras-like in neurons) GTPase as a candidate DAT-interacting
protein. Using biochemical, cellular imaging, and knockdown
approaches, we determined that Rin interacts directly with
DAT in a PKC-regulated manner and is required for PKC-
mediated DAT internalization.
Materials andMethods
Materials. Monoclonal rat anti-DAT antibodies were from Millipore
Bioscience Research Reagents and mouse anti-Rin antibodies (clone
27G2) were fromExAlpha Biologics orMillipore. Rabbit anti-DAT poly-
clonal antibody was a generous gift fromDr. Roxanne Vaughan (Univer-
sity ofNorthDakota, Grand Forks, ND). cDNAs encodingHA–RinQ78L
and HA–RinS34N (Spencer et al., 2002a) were kindly provided by Dr.
Doug Andres (University of Kentucky, Lexington, KY). Mouse anti-
green fluorescent protein (GFP) antibody and rat anti-HA antibody
(clone 3F10) were from Roche, and mouse anti-actin antibody was from
Santa Cruz Biotechnology. Mouse anti-HA (HA.11) antibody was acquired
from Covance. Horseradish peroxidase (HRP)-conjugated secondary anti-
bodies were from either Millipore Bioscience Research Reagents (anti-
mouse) or Santa Cruz Biotechnology (anti-rat), and goat anti-mouse Fc
fragment coupled to horseradish peroxidase was from Jackson ImmunoRe-
search. Fluorescently conjugated secondary antibodies and transferrin were
from Invitrogen. [3H]DA (dihydroxyphenylethylamine 3,4-[ring-2,5,6,-
3H])was fromPerkinElmerLife andAnalytical Sciences, and sulfo-NHS-SS-
biotin was from Pierce. Phorbol 12-myristate 13-acetate (PMA) and
GBR12909(1-[2-[bis(4-fluorophenyl)-methoxy]ethyl]-4-[3-phenylpropyl]
piperazine) were from Tocris Cookson. All other chemicals and reagents
were from Sigma-Aldrich and Thermo Fisher Scientific and were of the
highest grade available.
Yeast two-hybrid screen. A bait encoding human DAT amino acids
587–596 was constructed by amplifying hDAT cDNA region 1778–1807
with primers containing NotI and BglII sites and was cloned in-frame
into the pSOS vector (Stratagene) at the NotI/BglII sites. The pSOS–
DAT(586–597) bait was used to screen a CytoTrap XR substantia nigra
cDNA library cloned into the pMyr vector (Stratagene). Positive interac-
tions rescue Ras activity and permit yeast growth at the restrictive tem-
perature. Positive clones were picked and underwent secondary and
tertiary screening to rule out false positives attributable to temperature
reversion. PlasmidDNAwas isolated from tertiary positive clones, trans-
formed into DH5E bacteria (Invitrogen), amplified in liquid culture,
and purified, and sequences were determined (Genewiz).
Cell culture and transfections. PC12 cells weremaintained at 37°C, 10%
CO2 in DMEM (high glucose), 5% horse serum (Hyclone), and 5%
bovine calf serum (Invitrogen) supplemented with 2 mM glutamine, 102
U/ml penicillin/streptomycin. Stably transfected PC12 cells expressing
wild-type and 587–590(4A) DAT were maintained as described previ-
ously (Melikian and Buckley, 1999; Loder and Melikian, 2003; Boud-
anova et al., 2008) under selective pressure with 0.2 mg/ml G418
(Invitrogen). HEK293 cells were grown in DMEM, 10% fetal bovine
serum, 2mMglutamine, and 102U/ml penicillin/streptomycin, 37°C, 5%
CO2. The human neuroblastoma cell line SK-N-MC was obtained from
American Type Culture Collection and was maintained inMEM supple-
mented with 10% fetal bovine serum, 2 mM glutamine, and 102 U/ml
penicillin/streptomycin, 37°C, 5% CO2. HEK293 cells were transiently
transfected with Lipofectamine 2000, according to the instructions of the
manufacturer, using 2 g of total DNA/7  105 cells, incubating with
DNA/Lipofectamine complexes with cells 4 h for maximal cell viability.
PC12 cells were transfected either by electroporation or using Lipo-
fectamine 2000. For electroporation, 18.2 g of DNA/1.1  107 PC12
cells in 0.75 ml of electroporation buffer (in mM: 137 NaCl, 5.0 KCl, 0.7
Na2HPO4, 6.0 glucose, and 20 HEPES, pH 7.05) was combined in 4 mm
cuvettes and were electroporated using an exponential decay protocol at
300 V, 500 F. Cells were resuspended in PC12 media supplemented
with 3 mM EGTA and recovered 30 min, 37°C with occasional inversion.
Cells were collected by centrifugation, resuspended in PC12 media, and
plated as indicated. For Lipofectamine 2000 transfections, PC12 cells
were seeded 1 d before transfection at 1  106 cells per well (six-well
plates coated with 0.5 mg/ml poly-D-lysine; biochemical assays) or
2.25 105 per well (glass coverslips coated with 1.0mg/ml poly-D-lysine
for microscopy) in antibiotic-free PC12 media. Cells were transfected
with either 4 g (six-well plates) or 0.8 g (glass coverslips) total DNA
at a 2.5:1 Lipofectamine/DNA ratio, according to the instructions of
the manufacturer. Transfection solutions were replaced with fresh
antibiotic-freemedia 16–24 h after transfection, and cells were assayed as
described for each experiment. For SK-N-MC cells, 2.25 105 cells per
well were plated 1 d before transfection in antibiotic-freemedia on either
glass coverslips coated with 0.25mg/ml poly-D-lysine (microscopy) or in
uncoated 24-well tissue cultureware plates (uptake assays). Cells were
transfectedwith 0.3g of totalDNAperwell at a 2:1 Lipofectamine/DNA
ratio, according to the instructions of the manufacturer. Transfection
solutions were replaced with fresh, antibiotic-free media 4 h after trans-
fection, and cells were assayed as described for each experiment.
Coimmunoprecipitations. One  106 PC12 or PC12 cells stably ex-
pressing either wild-type or 587–590(4A) DAT were seeded in poly-D-
lysine-coated six-well plates 1 d before experiments. Cells were treated as
indicated, lysed in coimmunoprecipitation (co-IP) buffer (50 mM Tris,
pH 7.4, 100mMNaCl, 1% Triton X-100, 10% glycerol, and 1mM EDTA)
containing protease inhibitors (1.0 mM PMSF and 1.0 g/ml each leu-
peptin, aprotinin, and pepstatin) and phosphatase inhibitors (10 mM
sodium fluoride and 1 mM sodium orthovanadate), 30 min, 4°C with
gentle shaking. Lysates were cleared by centrifugation (4°C), and protein
concentrations were determined using the BCA Protein Assay (Pierce)
with BSA standards. Equivalent amounts of cellular protein underwent
immunoprecipitation (overnight, 4°C) using Protein A/G beads (Pierce)
precoatedwith the indicated antibodies. Supernatants were concentrated
withMillipore spin filtration columns (10 kDamolecular weight cutoff),
and beads were washed three times with co-IP buffer. Proteins were
eluted by boiling in SDS-PAGE sample buffer containing 2 M urea (final
concentration), and proteins were separated on 10% SDS-PAGE gels.
After transfer to nitrocellulose, immunoblotswere blockedwith 5%non-
fat dry milk, 0.1% Tween 20, and PBS, and proteins were detected with
the indicated primary antibodies. To avoid detecting mouse IgG light
chain in the immunoprecipitation complex, immunoreactive Rin bands
were detected with goat anti-mouse Fc fragment coupled to HRP. Stan-
dard secondary antibodies conjugated to HRP were used to detect all
other immunoreactive proteins. HRP-positive bands were visualized by
reacting withDuraWest Substrate (Pierce) and imagingwith a VersaDoc
imaging system (Bio-Rad). Nonsaturating bands were quantified using
Quantity One software (Bio-Rad) and were normalized to the amount of
DAT immunoprecipitated in the same reaction.
glutathione S-transferase pull downs. hDAT cDNA nucleotides 1778–
1879, corresponding to DAT amino acids 587–617, were amplified by
PCR, and the productwas cloned into the pGEX-5x-1 vector (GEHealth-
care) downstream of and in-frame with glutathione S-transferase (GST).
The DAT 587–590(4A) mutation was generated using QuikChange Mu-
tagenesis (Stratagene), and all construct sequences were confirmed by
dideoxy chain termination sequencing (Genewiz). Plasmids were trans-
formed into Escherichia coli BL21 and were cultured and induced with
isopropyl--D-thiogalactopyranoside at 28°C tominimize fusion protein
degradation, although some degradation was apparent in many of the
assays. Fusion proteins were purified with glutathione agarose according
to the instructions of the manufacturer, and protein purification was
monitored at each step by SDS-PAGE with Coomassie staining. For pull
downs, PC12 postnuclear supernatants were prepared with a ball-
bearing cell homogenizer as described previously (Melikian and Buckley,
1999). The indicated amount of cell homogenate was incubated with
equivalent amounts of glutathione agarose bound to GST, GST–DAT
587–617, orGST–DAT587–590(4A), 37°C, 1 h. Beadswerewashed three
times with 50 mM Tris, pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% Triton
X-100, and 10% glycerol and were boiled in SDS-PAGE sample buffer, 5
min to elute bound proteins. Samples were resolved on SDS-PAGE gels
andwere immunoblotted for Rin andGST (to confirm pull down). Non-
saturating Rin bands were imaged as described above for coimmunopre-
cipitations, normalizing to GST band densities (GST  GST–DAT in
cases when degradation occurred).
Fluorescence resonance energy transfer (FRET) (Schmid and Sitte,
2003) was measured with a Carl Zeiss Axiovert 200 epifluorescence mi-
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croscope. The “three-filter method” was performed as described previ-
ously (Bartholomaus et al., 2008). Images were taken using 63 oil-
immersion objectives and Ludl filter wheels allowing a rapid excitation
and emission filter exchange. We used HEK293 cells that were main-
tained and transiently transfected with plasmid cDNA (1.7g) bymeans
of the calciumphosphate coprecipitationmethod as described previously
(Sucic et al., 2010). The Ludl filter wheels were configured as follows:
cyan fluorescent protein (CFP) (IDonor; excitation, 436 nm; emission, 480
nm; and dichroic mirror, 455 nm), yellow fluorescent protein (YFP)
(IAcceptor; excitation, 500 nm; emission, 535 nm; and dichroicmirror, 515
nm), and FRET (IFRET; excitation, 436 nm; emission, 535 nm; and di-
chroic mirror, 455 nm). Images were taken with a CCD camera (Cool-
snap fx; Roper Scientific). Background fluorescence was subtracted from
all images. We analyzed the images pixel by pixel using NIH ImageJ
(version 1.43b;Wayne Rasband, National Institutes of Health, Bethesda,
MD) and the NIH ImageJ plug-in PixFRET (pixel-by-pixel analysis of
FRET with NIH ImageJ, version 1.5.0; Feige et al., 2005) with which
spectral bleed-through parameters for the donor bleed through (BT) and
the acceptor BT were determined and normalized FRET image (NFRET)
was calculated in the following way:
NFRET 
IFRET  BTDonor * IDonor  BTAcceptor * IAcceptor
IDonor * IAcceptor * 100,
The mean NFRET was measured at the plasma membrane (predefined as
the region of interest) using the computed NFRET image. The regions of
interest were selected in the CFP (donor) or YFP (acceptor) image (to
avoid bleaching-associated bias) and transmitted to the NFRET image by
the NIH ImageJ Multi Measure Tool. As negative control, we used the
CFP-labeled form of DAT or Rin with a membrane-bound form of YFP
(Hein et al., 2005) that was kindly provided byViacheslavNikolaev (Uni-
versity of Wu¨rzburg, Wu¨rzburg, Germany). As positive controls for
membrane proteins, we used the serotonin transporter (SERT) tagged
with CFP and YFP on its cytoplasmic N and C termini, respectively (to
yield C-SERT-Y; Just et al., 2004).We taggedDAT and Rin with CFP and
YFP to reveal C-DAT and Y-DAT (Bartholomaus et al., 2008) as well as
C-Rin and Y-Rin to compare the FRET values in Rin and DAT (and rule
out any bias introduced by the different tags, although they differ only
in a few amino acids). We also transfected HEK293 cells with combi-
nations of C-DAT and Y-DAT as well as C-Rin and Y-Rin. The statis-
tical significance of differences between the experimental conditions
was determined using one-way ANOVA followed by Tukey’s multiple
comparison test.
Immunocytochemistry and microscopy. Cells were transfected with the
indicated cDNAs at a 1:1 ratio and were assayed 48 h after transfection.
Cells were treated as indicated, rinsed in PBS, and fixed in 4% parafor-
maldehyde prepared in PBS, 10 min, 25°C. Cells were blocked and per-
meabilized in blocking solution (PBS, 1% IgG/protease-free BSA, 5%
goat serum, and 0.2% Triton X-100), 30 min, room temperature, fol-
lowed by incubation with the indicated primary antibodies, 45 min,
25°C. Cells were washed with PBS and incubated with Alexa Fluor 594-,
Alexa Fluor 405-, and Alexa Fluor 488-conjugated secondary antibodies
(as indicated), 45 min, 25°C. Cells were washed with PBS, dried, and
mounted on glass slides with ProLong Gold mounting medium (Invit-
rogen). Immunoreactive cells were visualized as described previously
(Holton et al., 2005) with a Carl Zeiss Axiovert 200Mmicroscope using a
63, 1.4 numerical aperture oil-immersion objective, and 0.4moptical
sections were captured through the z-axis with a Retiga-1300R cooled
CCD camera (Qimaging) using Slidebook 5.0 software (Intelligent
Imaging Innovations). z-stacks were deconvolved with a constrained
iterative algorithm using measured point-spread functions for each flu-
orescent channel. All images shown are single 0.4mplanes through the
center of each cell. For CTX colocalization studies, before fixing and
staining cells, cells were incubated with 2.0 g/ml Alexa Fluor 594-
conjugated cholera toxin subunit B (CTX), 1 h, 4°C and were washed
extensively in PBS2 and 0.2% IgG/protease-free BSA. To quantify the
percentage of DAT that colocalized with Rin (by volume, i.e., counting
voxels) in CTX-positive and CTX-negative regions, we assessed each
z-stack over a broad range of threshold triplets (i.e., a threshold for each
of the three channels). Given the inherent signal intensity variability
among cells and to avoid biasing our analysis, a range of thresholds
(picked manually while viewing three-dimensional images) was deliber-
ately set to be somewhat wider than the likely range. The lowest threshold
allowed for some diffuse background fluorescence to remain; the highest
threshold clearly was eroding the margins of labeled structures. Colocal-
ization percentages were calculated at 10 equally spaced thresholds for
each species, resulting in 1000 colocalization pairs for each cell. For each
cell, we examined the sensitivity (to the threshold) of the raft and non-
raft colocalization percentages by creating a surface plot for the two
percentages. AWilcoxon’s matched-pairs signed-rank test indicated sig-
nificant difference across all thresholds. Therefore, single measurements
at the median threshold were chosen for statistical analysis and data
presentation.
Internalization assay. Relative initial internalization rates were mea-
sured using reversible biotinylation as described previously (Loder and
Melikian, 2003; Holton et al., 2005; Boudanova et al., 2008). Cells were
cotransfected with DAT and the indicated constructs at a 1:2 DAT/other
cDNA ratio and were assayed 48–72 h after transfection. Briefly, trans-
fected cells were biotinylated twice, 15 min, 4°C with 2.5 mg/ml NHS-
SS-biotin and were quenched twice, 15 min, 4°C with 100 mM glycine.
Cells were rapidly warmed to 37°C and incubated with or without 1 M
PMA, 10 min, 37°C, followed by rapidly cooling to 4°C to stop internal-
ization. Residual surface biotin on internalization samples and str-
ipping controls was stripped by reducing twice for 15 min, 4°C with 50
Figure 1. Rin is expressed in PC12 cells and rat striatum and specifically coimmunoprecipi-
tateswith DAT.A, Rin expression in catecholaminergic tissue and cell lines. Twentymicrograms
of PC12 and SK-N-MC lysate and 150g of rat striatal lysate were resolved by SDS-PAGE and
immunoblotted with mouse anti-Rin antibodies. B, Coimmunoprecipitations. DAT was immu-
noprecipitated from equivalent amounts lysate from PC12 cells transfected with either vector
() or DAT (). Control immunoprecipitations were performed using anti-TfR antibodies or
with Protein A/G beads alone. Bead eluents (Bead) and 1⁄10th supernatant volumes (Sup) were
resolved by SDS-PAGE and immunoblotted with an anti-Rin antibody. Representative blots are
shown (n 3). C, Coimmunoprecipitations from rat striatal synaptosomes. Immunoprecipita-
tions were performed with solubilized rat striatal synaptosomes using Protein A beads coated
with rabbit anti-DAT antibodies or rabbit IgG alone. Eluents were resolved by SDS-PAGE, and
immunoreactive bands were detected with the indicated antibodies. A representative blot is
shown (n 2).
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mM tris(2-carboxyethyl)phosphine. Cells were lysed, and biotinylated
proteins were isolated with streptavidin agarose and analyzed by SDS-
PAGE and immunoblotting for DAT. Immunoblots were probed in
parallel for GFP and HA to confirm cotransfection with CFP–Rin (wild-
type) and HA-tagged Rin mutants. Internalization rates were calcu-
lated as the percentage DAT internalized over 10 min compared with
total surface protein labeled at time 0. Assays were only included if strip-
ping efficiencies were90%.
Short hairpin studies. Short hairpin RNAs (shRNAs) targeting 29 nt
spans of the humanRinmRNAcloned into the pGFP-V-RS vector, which
coexpresses turbo GFP, were purchased from Origene. hRin shRNA
sequences were as follows: hRin228, GGTCCAGAGAGTACAAGG
TGGTAATGCTG.
hRin knockdown efficiencies were assessed
inHEK293T cells, taking advantage of their rel-
atively high transfection efficiency. Two 105
cells were seeded into six-well culture plates 1 d
before transfection. Cells were transfected us-
ing Lipofectamine 2000 (Invitrogen), using 4.0
g of plasmid DNA per well and a Lipo-
fectamine/DNA ratio of 2.5:1. Media was
changed 4 h after transfection, and at 72 h after
transfection, GFP-positive cells were enriched
by flow cytometry (University of Massachu-
setts Medical School Flow Cytometry Core Fa-
cility). Cells were collected by centrifugation
and lysed in RIPA buffer, and Rin levels were
measured by quantitative immunoblotting
equivalent amounts of cell lysate, normalizing
to actin as a loading control. For knockdown
experiments, SK-N-MC cells were transfected
with Lipofectamine 2000 as described above,
with equal amounts of DAT and the indicated
plasmids, and were plated on either poly-D-
lysine-coated glass coverslips (immunofluo-
rescence) or 24-well tissue cultureware plates
(uptake assays). All studies were conducted
72 h after transfection, and shRNA expression
was confirmed by detecting GFP coexpression,
by microscopy or immunoblot.
Antibody internalization assays. SK-N-MC
cells were cotransfected with hDAT encoding
an HA epitope tag in the second extracellular
loop (ELA–HA–DAT) (Sorkina et al., 2006)
and the indicated control or shRNAcDNAs at a
1:1 ratio. At 72 h after transfection, surface
DAT was labeled with 2 g/ml mouse anti-HA
antibody, 30min, room temperature. Tomon-
itor PKC-induced internalization, cells were
extensively washed and rapidly warmed to 37°C
in PBS2 supplemented with 0.2% IgG and
protease-free BSA, 0.18% glucose, and 1 M
PMAandwere incubated in the samesolution,15
min, 37°C. Cells were rapidlywashed in cold PBS
to inhibit additional endocytic trafficking and
were fixed in 4% paraformaldehyde in PBS, 10
min, roomtemperature.Residual surfaceHAan-
tibody was blocked by incubating in 20 g/ml
goat anti-mouse secondary antibody in 5% nor-
mal goat serum and 1% IgG/protease-free BSA,
45 min, room temperature. Cells were washed
three times in PBS and were permeabilized in
0.2% saponin in PBS containing 1% IgG and
protease-free BSA, and 5% normal goat serum,
30 min, room temperature. Internalized HA an-
tibody was detected by probing cells with goat
anti-mouse secondary antibody conjugated to
Alexa Fluor 594 (1:5000), 45min, room temper-
ature. Cells were washed three times in PBS, and
coverslips were mounted in ProLong Gold. Im-
ages of GFP-positive cells were captured as described above formicroscopy,
using identical exposure times for all cells. For quantification, GFP-positive
cells were scored blindly for PMA-induced DAT internalization, which was
defined as the presence of multiple large (100 nm) intracellular puncta
distinct from the plasmamembrane and visible in all three cell perspectives
(x–y, x–z, and y–z axes). The percentageGFP-positive cells exhibiting PMA-
induced DAT internalization for each transfection condition was averaged
across multiple experiments, and significant differences in PMA-induced
internalization were determined by one-way ANOVA with Dunnett’s post
hoc analysis compared with vector-transfected cells.
[3H]DA uptake assays. Transfected cells were seeded onto 24-well
plates, and [3H]DA uptake was measured 48 h after transfection as re-
Figure 2. DAT and Rin colocalization at the plasma membrane is enriched in lipid raft microdomains. Immunofluorescence.
PC12 cellswere cotransfectedwithDATandCFP–Rin andwere fixed and stainedas follows.A, Cellswere stainedwith anti-DATand
anti-GFP antibodies and imaged as described inMaterials andMethods. Boxes indicate an enlargement of the areas indicatedwith
white boxes in themerged images.B, Cells were labeledwith Alexa Fluor 594–CTX andwere subsequently stainedwith anti-DAT
and anti-GFP antibodies and imaged as described in Materials andMethods. C, Enlargement of the boxed areas from images in B.
Arrows indicate DAT-immunoreactive pixels that colocalize with neither Rin (blue) nor CTX (red). Arrowheads indicate foci of
DAT/Rin colocalization that also colocalize with CTX. D, Average data. DAT/Rin colocalization in CTX-positive (CTX) and CTX-
negative (CTX) cell regions was measured at 10 independent thresholds per channel, as described in Materials and Methods.
Average data at the median threshold are expressed as percentage SEM DAT/Rin colocalization. *p 0.0001, significantly
different fromCTX, paired t test; n 16.
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ported previously (Loder and Melikian, 2003;
Boudanova et al., 2008). Briefly, cells were
rinsed and preincubated in KRH buffer (120
mM NaCl, 4.7 mM KCl, 2.2 mM CaCl2, 1.2 mM
MgSO4, 1.2 mM KH2PO4, 0.18% glucose, and
10 mM HEPES, pH 7.4) at for 37°C for 30 min
with the indicated drugs. Uptake was initiated
by adding 1.0 M [3H]DA (PerkinElmer Lief
and Analytical Sciences) containing 105 M
pargyline and 105 M ascorbic acid. Assays
proceeded for 10 min (37°C) and were termi-
nated by rapidly washing cells with ice-cold
KRH buffer. Cells were solubilized in scintilla-
tion fluid, and accumulated radioactivity was
determined by liquid scintillation counting in a
Wallac Microbeta scintillation plate counter.
Nonspecific uptakewas defined in the presence
of 10MGBR12909 and averaged5%of total
counts measured. Data analysis was performed
using Microsoft Excel and GraphPad Prism
Software.
Results
Rin is a DAT-interacting protein
We previously identified a 10 aa region en-
coded in hDAT C-terminal residues 587–
596 that is required for PKC-regulatedDAT
internalization(Holtonetal., 2005)andthat
negatively regulates basal DAT endocytic
rates (Boudanova et al., 2008). Our major
aim in the current studywas to identify pro-
teins that interactedwith thehDATresidues
587–596 (FREKALAYAIA) and that were
mechanistically integral to PKC-regulated
DATtrafficking.Using this sequence asbait,
we used the hSOS rescue system to screen a
human substantia nigra cDNA library. The
advantage of this approach is that library
cDNAs are myristylated and thereby an-
chored at the plasma membrane, whereas
baits are cloned in-frame with the Ras gua-
nine nucleotide exchange factor, hSOS.
Thus, interactions between bait and library
preyoccur at ornear theplasmamembrane,
mimicking circumstances during DAT en-
docytic trafficking. Screens take place in the
temperature-sensitive mutant yeast strain
cdc25H, which lacks Ras signaling and is
unable to grow at the restrictive temperature. Protein–protein inter-
actions localize hSOS to the plasma membrane, activate Ras signal-
ing, and rescue the temperature-sensitive phenotype. In our initial
studies, we attempted to use the entire DAT C terminus as bait.
However, this bait alone was capable of rescuing growth in the ab-
senceof library coexpressionandwas thusdeemedunsuitable as bait
in the library screen. However, the FREKLAYAIA sequence (hDAT
residues 587–596) alone did not rescue yeast growth (data not
shown) andwas thereforeused as bait in the screen.We isolated four
clones that rescued yeast growth at the restrictive temperature.
Sequence analysis revealed that clone H19 corresponded to the
small neuronal GTPase Rin, also known as Rit2. Retransforming
purified hRin plasmid with the DAT 587–596 bait also yielded a
positive interaction and confirmed the protein–protein interac-
tion (data not shown).
We first investigated whether Rin was expressed in dopami-
nergic cells, to determine whether there was a physiologically
relevant context for cellular DAT/Rin interactions. Immunoblots
revealed a single 25 kDa immunoreactive band in catecholamin-
ergic cells lines and neuronal tissues, including the rat pheochro-
mocytoma PC12, the human neuroblastoma SK-N-MC, as well
as in rat striatum (Fig. 1A). In addition to its neuronal expres-
sion, we also detected Rin in rat muscle and liver, primary cul-
tured rat astrocytes, andmouse embryonic kidney cells, as well as
in non-neuronal cell lines HeLa, COS-1, CHO, IMCD3, and
HEK293 (data not shown). Given that the mRNA expression of
Rin is reported to be restricted to neuronal tissue (Lee et al.,
1996), we were concerned that the anti-Rin antibody might be
also detecting Rit, the closest homolog of Rin. Because both pro-
teins are 25 kDa and could not be distinguished on the basis of
electrophoretic mobility, we used Rin and Rit GFP fusion pro-
teins to test for this possibility. Both constructs were expressed in
PC12 cells and exhibited the expected molecular weight shift, as
confirmed by immunoblotting with anti-GFP antibodies (data
Figure 3. Rin and DAT oligomerization as demonstrated by FRET microscopy in intact cells. HEK293 cells were transiently
transfected with cDNAs encoding CFP- or YFP-tagged proteins as indicated, and epifluorescence microscopy was performed 2 d
after transfection. A, The first and second columns show images obtained with CFP and YFP filter sets, respectively; the third
column displays a corrected and normalized FRET image (NFRET) establishedwith PIXFRET. A look-up table of the color code used is
presented in the last column. All images shown are representative of three to seven experiments. In all images, background
fluorescence was subtracted. B, Averaged data. Normalized FRET efficiencies (NFRET values) are given for cells expressing the
following constructs: C-Rin and membrane-bound YFP (membr-YFP; n 15), Y-DAT and membr-CFP (n 25), C-TfR and Y-Rin
(n 20), C-Rin andY-Rin (n 16), C-SERT andY-Rin (n 27), C-rGAT1 andY-Rin (n 30), C-DAT andY-Rin (n 24), C-Rin and
Y-DAT (n 20), C-DAT and Y-DAT (n 23), and C-TfR and Y-TfR (n 37). All values were analyzed by one-way ANOVA with
Dunn’s multiple comparison test. *p 0.001, significantly different from (YFP–DAT and membr-CFP), (CFP–Rin and YFP–Rin),
and (Rinandmembr-YFP). **p0.001, significantlydifferent from(CFP–TfRandYFP–Rin), (CFP–RinandYFP–Rin), and (Rinand
membr-YFP). See Table 1 for statistical analysis of complete dataset.
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not shown). However, the anti-Rin antibody only detected GFP–
Rin and notGFP–Rit (data not shown), confirming its specificity.
Thus, Rin protein appears to be expressed in neuronal, as well as
non-neuronal, tissues and cell lines.
We next asked whether DAT and Rin interact in mammalian
cells. Coimmunoprecipitations using an antibody directed
against the DAT N terminus isolated Rin from DAT-PC12 cell
lysates, confirming that Rin associates with DAT in mammalian
neuroendocrine cells (Fig. 1B). Rin coimmunoprecipitated with
DAT specifically and was not isolated from nontransfected PC12
cells, with antibodies directed against the transferrin receptor, or
when empty Protein A/G beads were used (Fig. 1B). We also
detected DAT/Rin interactions when DAT was immunoprecipi-
tated from rat striatal synaptosomes (Fig. 1C), confirming that
the DAT/Rin interaction occurs in brain. It should be noted that
we were unable to detect the DAT/Rin interaction when a
C-terminus-directed anti-DAT antibody was used for immuno-
precipitation, despite quantitative DAT pull down (data not
shown). Moreover, we were not able to perform the reciprocal
coimmunoprecipitation, because the available Rin antibody does
not effectively immunoprecipitate Rin.
Although the Rin monoclonal antibody recognizes a single
band on immunoblots, it does not recognize Rin in situ, nor does
it immunoisolate Rin from cell lysates. Furthermore, our
attempts to raise rabbit anti-peptide antibodies against Rin
domains divergent from its homolog Rit did not yield immu-
noreactive sera. Therefore, we used CFP-tagged Rin to ask
whetherDATandRin colocalize in cells and, if so, inwhat cellular
regions. In PC12 cells cotransfected with CFP–Rin and DAT,
staining was clearly detected as a ring around the cell perimeter
(Fig. 2A), consistent with its predicted plasma membrane local-
ization. CFP–Rinwas also detected primarily at the cell perimeter
(Fig. 2A), consistent with reports that it localizes to the plasma
membrane (Heo et al., 2006). We observed substantial DAT and
Rin colocalization at the plasma membrane, and DAT and Rin
colocalization was limited to discrete foci within the plasma
membrane (Fig. 2A, arrowheads). We also observed areas in
which DAT did not appear to colocalize with Rin (Fig. 2A, ar-
rows). DAT is distributed between lipid raft and non-raft mi-
crodomains within the plasma membrane (Adkins et al., 2007;
Foster et al., 2008; Cremona et al., 2011), and we asked whether
the focal distribution of DAT/Rin colocalization correlated with
the expression of DAT in membrane microdomains. To answer
this question, we coexpressed DAT and CFP–Rin and labeled
lipid rafts with Alexa Fluor 594-conjugated CTX, which specifi-
cally labels membrane rafts via binding to GM1 ganglioside
(Sandvig and van Deurs, 2000). Cells were then fixed, and DAT
and CFP–Rin were stained as described in Materials and Meth-
ods, using Alexa Fluor 488- and Alexa Fluor 405-conjugated sec-
ondary antibodies to visualize DAT and Rin in the green and blue
channels, respectively (Fig. 2B,C). Visually we observed striking
colocalization of DAT and Rin in CTX-positive regions (Fig. 2C,
arrowheads).We then quantitatively compared the percentage of
DAT/Rin colocalization in CTX-positive versus CTX-negative
regions. At virtually all the thresholds tested, there was more
DAT/Rin colocalization in rafts than in non-rafts (n 16). Only
at a very few extreme thresholds for a few cells (data not shown)
was DAT/Rin colocalization higher (by a small amount) in CTX-
negative regions than in CTX-positive regions. Analysis at the
median threshold values for each cell revealed significantly more
DAT/Rin colocalization in raft versus non-raft populations
(80.1  2.4% in CTX-positive vs 57.0  4.9% in CTX-negative
regions; p 0.0001, paired t test; n 16).
To further evaluate whether DAT and Rin directly interact in
living cells, we used FRET microscopy (Schmid and Sitte, 2003)
using the three-filter method (Xia and Liu, 2001) as described by
Feige et al. (2005), which achieves quantitative visualization of
protein oligomerization in intact cells andwhich generates NFRET
images. The results are shown in Figure 3 and Table 1. To provide
Figure 4. Rin interacts with the DAT C terminus. GST pull-down assays. PC12 homogenate
was incubated with either GST or GST–DAT 587–617, 1 h, 37°C. Complexes were isolated with
glutathione agarose, and Rinwas detected by immunoblot as described inMaterials andMeth-
ods.A, Rin is isolatedwith the DAT C terminus but not GST alone.B, Concentration dependence.
GST–DAT 587–617 was incubated with increasing concentrations of PC12 homogenate, 1 h,
37°C, followed by isolation of complexeswith glutathione agarose. Top, Representative immu-
noblot probed for Rin. Bottom,Averageddata. Results are expressedaspercentagemaximal Rin
signal versus log PC12 homogenate concentration (milligrams per milliliters) and were fit to a
sigmoidal dose–response curve (r 2 0.98, n 3).
Table 1. Statistical analysis of NFRET values
FRET Pair #1 FRET Pair #2 Significant?
CFP–DAT YFP–Rin CFP–SERT YFP–Rin Yes*
CFP–DAT YFP–Rin CFP–rGAT1 YFP–Rin Yes*
CFP–DAT YFP–Rin CFP–TfR YFP–TfR NS
CFP–DAT YFP–Rin CFP–TfR YFP–Rin Yes*
CFP–DAT YFP–Rin CFP–Rin YFP–Rin Yes*
CFP–DAT YFP–Rin YFP–DATmembr-CFP Yes*
CFP–DAT YFP–Rin CFP–Rinmembr-YFP Yes*
CFP–DAT YFP–Rin CFP–Rin YFP–DAT NS
CFP–DAT YFP–Rin CFP–DAT YFP–DAT NS
CFP–SERT YFP–Rin CFP–rGAT1 YFP–Rin NS
CFP–SERT YFP–Rin CFP–TfR YFP–TfR Yes*
CFP–SERT YFP–Rin CFP–TfR YFP–Rin NS
CFP–SERT YFP–Rin CFP–Rin YFP–Rin NS
CFP–SERT YFP–Rin YFP–DATmembr-CFP NS
CFP–SERT YFP–Rin CFP–Rinmembr-YFP NS
CFP–SERT YFP–Rin CFP–Rin YFP–DAT Yes**
CFP–SERT YFP–Rin CFP–DAT YFP–DAT Yes*
CFP-rGAT1 YFP–Rin CFP–TfR YFP–TfR Yes*
CFP-rGAT1 YFP–Rin CFP–TfR YFP–Rin NS
CFP-rGAT1 YFP–Rin CFP–Rin YFP–Rin NS
*p 0.001, **p 0.05, one-way ANOVA with Dunn’s multiple comparison test.
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a reference for membrane protein oligomerization, we coex-
pressed CFP- and YFP-tagged DAT, which have been shown to
homo-oligomerize by both biochemical approaches (Hastrup et
al., 2001; Sorkina et al., 2003; Miranda et al., 2004; Bartholomaus
et al., 2008) and FRETmicroscopy in various cell lines (Sorkina et
al., 2003; Miranda et al., 2004; Bartholomaus et al., 2008) and
transfected neurons (Egan˜a et al., 2009). In addition, we used
SERT tagged with CFP and YFP on its cytoplasmic N and C
termini, respectively (C-SERT-Y), i.e., a transporter construct
predicted to produce a strong homotypic FRET signal (Egan˜a et
al., 2009). Coexpressing C-DAT and Y-DAT or C-SERT-Y
resulted in enriched plasma membrane fluorescence and, as ex-
pected, robust NFRET signals (18.89 0. 1.16, n 23 and 48.39
2.54, n 28, respectively; Fig. 3B, Table 1). Similarly, expressing
fluorescently tagged Rin proteins resulted in predominant
plasmamembrane fluorescence (Fig. 3A). Coexpression of CFP–
DAT and YFP–Rin resulted in an NFRET value of 17.54  1.30
(n 24; Fig. 3A,B), which was significantly higher than fluores-
cent Rin proteins (p  0.001, one-way ANOVA with Dunn’s
multiple comparison test) and not significantly different from
either coexpressed CFP–DAT and YFP–DAT or CFP–Rin and
YFP–DAT.This confirms thatDATandRin interact in living cells
and that the different fluorescent tags do not influence the signal.
To control for the possibility of nonspecific FRET of fluorescent
proteins in the plasma membrane, we tested whether Rin would
generate significant FRET interaction with membrane anchored
YFP; coexpression with CFP–Rin yielded an NFRET value of
5.40  0.49 (n  15; Fig. 3B), which was significantly less than
any DAT/Rin combination (p  0.001). Apparently, this
membrane-attached YFP can serve as a weak acceptor for CFP
fluorophores attached to proteins integral tomembranes; indeed,
some spurious FRET signal was visible during coexpression with
CFP–DAT, but only in a cytosolic compartment (data not
Figure 5. DAT/Rin interactions are regulated by PKC activation and are sensitive to DAT
C-terminal residues 587–590. A–C, Coimmunoprecipitations. PC12 cells stably expressing ei-
ther wild-type DAT (A) or DAT 587–590(4A) (B) were pretreated with either 1 M BIM or
vehicle, 20 min, 37°C, followed by treatment with either vehicle or 1M PMA, 30 min, 37°C.
Cellswere lysed, andDATwas immunoprecipitated fromequivalent amounts of cellular protein.
Immunoprecipitants were resolved by SDS-PAGE and immunoblotted for both DAT and Rin.
Left, Representative immunoblots. Right, Averaged data. Rin signals fromnonsaturating bands
were normalized to DAT signals and are expressed as percentage vehicle signal SEM. *p
0.002, significantly different from vehicle control (one-way ANOVAwith Tukey’s multiple com-
parison test; n 4). C, Basal Rin interaction with wild-type versus 587–590(4A) DAT. Left,
Representative immunoblot. Right, Averaged data. Rin signals from nonsaturating bandswere
normalized to DAT signals and expressed as percentagewild-type signal SEM. *p 0.0005,
significantly different fromwild-typeDAT (Student’s t test;n3).D, GSTpull downs.GST fused
to either wild-type or DAT 587–590(4A) C termini were induced and isolated on glutathione
sepharose as described in Materials and Methods. Equivalent amounts of GST–DAT fusion pro-
teinswere incubatedwith PC12 homogenates, and bound proteinswere resolved by SDS-PAGE
and immunoblotted for both Rin and GST. Left, Representative immunoblot. Right, Averaged
data. Rin densitieswere normalized to total GST pulled down for each sample and are expressed
as percentage SEMRin isolated comparedwithwild-type GST–DAT. *p 0.04, significantly
different from wild-type GST–DAT (Student’s t test; n 5).
Figure6. PKC-inducedDAT internalization requires Rin activity. Internalization assays. PC12
cells were cotransfected with DAT and the indicated Rin or control cDNAs and were assayed
48–72 h after transfection. Relative DAT internalization rates over 10 min were measured by
reversible biotinylation during treatment with or without 1 M PMA, 37°C as described in
Materials andMethods. Top, Representative immunoblots showing total surface DAT at time 0
(T), strip controls (S), and internalized DAT under vehicle-treated (V) and PMA-treated (P)
conditions. Bottom, Average data. veh, Vehicle. Data are expressed as percentage SEM DAT
internalized/10 min compared with total surface DAT at t  0. *p  0.001, **p  0.05,
significantly different from vehicle-treated control (Student’s t test; n 4).
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shown); therefore, the transitional interaction most likely oc-
curred in the endoplasmic reticulum. Importantly, Rin proteins
do not interact with themselves as revealed by an NFRET value of
6.24 0.90 (n 16; Fig. 3B).
We next asked whether the interaction of Rin with DAT was
specific to DAT or whether it extended either to other SLC6
transporters or generally to proteins that are rapidly endocytosis,
such as the transferrin receptor (TfR). To test potential Rin in-
teraction with other SLC6 neurotransmitter transporters, we
coexpressed Rin with either fluorescently tagged rat GABA
(CFP–GAT1) or human serotonin transporter (CFP–SERT).
Interestingly, CFP–GAT1 and CFP–SERT did not interact with
YFP–Rin (NFRET values of 6.55  0.64 and 7.58  0.77, respec-
tively; Fig. 3A,B). Neither condition differed significantly from
the CFP–Rin and membrane YFP negative control, and rGAT1
and Rin were significantly less than from DAT and Rin (p 
0.001) and from the positive control CFP–TfR and YFP–TfR
(NFRET value of 18.53  0.96) (p  0.001) but not from hSERT
and Rin (NFRET value of 7.58  0.77; n  27), respectively (Fig.
3B). To test for Rin interactions with rapidly internalizing surface
proteins, we coexpressed of YFP–Rin with CFP–TfR. This condi-
tion resulted in an NFRET value of 6.35 0.83, which was signif-
icantly less thatDAT/Rin FRETpairs and not significantly greater
than fluorescent Rin proteins or membrane-anchored fluores-
cent proteins with either DAT or Rin (Fig. 3B). Lack of a signifi-
cant TfR/Rin FRET signal was not attributable to inability of
fluorescently tagged TfR to form FRET pairs, because CFP–TfR
and YFP–TfR coexpression resulted in an NFRET value of 18.5
0.96, which was significantly greater than fluorescent TfR with
Rin and is consistent with the known TfR homodimerization
(Fig. 3B) (Alvarez et al., 1989).
We next tested whether DAT/Rin interactions relied specifi-
cally on the DAT C terminus. To test this, we performed in vitro
pull-down assays, using a GST fusion protein expressing DAT
C-terminal residues 587–617 to probe PC12 cell homogenates
lacking DAT expression. The GST–DAT 587–617 fusion protein
was sufficient to isolate Rin from PC12 homogenates, whereas
GST alone was not (Fig. 4A). Moreover, GST–DAT 587–617
recovered Rin from PC12 homogenates in a concentration-
dependentmanner (Fig. 4B). Togetherwith our yeast two-hybrid
co-IP and FRET data, these results demonstrate that DAT and
Rin directly interact in mammalian cells and brain and that their
interaction is mediated by the DAT C terminus, which encodes
the FREKLAYAIA sequence used as bait in the original yeast two-
hybrid screen.
PKC activation regulates DAT and Rin interactions
Our previous studies demonstrated that DAT residues 587–596
(FREKLAYAIA) encode elements that control DAT endocytic
rates in a PKC-sensitive manner (Boudanova et al., 2008). Spe-
cifically, 587–589 (REK) residues are required for PKC-induced
increases in DAT internalization. Moreover, mutating residues
587–590 accelerates basal DAT endocytic rates, suggesting that a
negative regulatory mechanism controls DAT endocytic rates.
Therefore, we asked whether DAT associations with Rin were
regulated by PKC activation andwhether residues in the 587–590
region played a role in DAT/Rin interactions. PC12 cells stably
expressing either wild-type DAT or the DAT 587–590(4A) mu-
tant were treated with 1 M PMA, 30 min, 37°C, and DAT/Rin
interactions were assessed by coimmunoprecipitation and im-
munoblot. PKC activation significantly increased wild-type
DAT/Rin interactions to 183.6 16.5% of basal DAT/Rin inter-
actions (p  0.005, Student’s t test; n  4) (Fig. 5A). PMA-
induced increases in wild-type DAT/Rin interactions were
blocked when cells were preincubated with the PKC inhibitor
BIM (Fig. 5A), demonstrating that the PMA-induced increase in
DAT/Rin interactions is PKC dependent. In contrast, PMA treat-
ment did not significantly increase Rin interactions with DAT
587–590(4A) (Fig. 5B), and pretreatment with BIM did not alter
DAT 587–590(4A)/Rin interactions. Moreover, under basal con-
ditions, DAT 587–590(4A) interactions with Rin were 300% of
wild-type DAT/Rin interactions (Fig. 5C). These results suggest
that DAT residues 587–590 are required for PKC-induced in-
creases in DAT/Rin interactions. Additionally, these results sug-
gest that DAT/Rin interactions increase in conditions were DAT
internalization rates are accelerated either by PKC activation or
mutating residues 587–590. To further test this possibility, we
performed GST pull downs using GST–DAT C terminus that
Figure 7. Guanyl nucleotide exchange is required for PKC-mediated Rin dissociation from DAT. Immunofluorescence. PC12 cells were cotransfected with DAT and the indicated Rin or control
cDNAs and were assayed 48 h after transfection. Cells were treated with or without 1M PMA, 30min, 37°C and were fixed, stained with anti-DAT or anti-GFP (to detect CFP–Rin) antibodies, and
imaged as described in Materials and Methods. Planes through the cell center are shown and are representative of 12–16 cells imaged per condition in instances in which PMA-induced
internalization was apparent (n 4).
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encoded the 587–590(4A) mutation
[GST–DAT(4A)]. GST–DAT(4A) iso-
lated significantly more Rin than
wild-type GST–DAT (164.6  21.8% of
wild-type levels) (Fig. 5D), consistent
with a role for residues 587–590 in modu-
lating DAT/Rin interactions.
Rin is required for PKC-mediated
DAT trafficking
We next asked whether DAT endocytosis
requires Rin activity, under either basal or
PKC-stimulated conditions. To address
this question, we used reversible biotiny-
lation to measure relative DAT internal-
ization rates in PC12 cells coexpressing
DAT with wild-type Rin, or constitu-
tively active (Q78L) or dominant-
negative (S34N) Rin mutants. The results
are shown in Figure 6. DAT internalized
robustly under control conditions and
PMA treatment significantly increased the
endocytic rate of DAT, both when DAT
was coexpressed with empty vector or
constitutively active RinQ78L. In con-
trast, coexpressing DAT with either wild-
type Rin or dominant-negative Rin S34N
completely inhibited PMA-stimulated
DAT endocytosis but had no effect on
basal DAT internalization rates. These re-
sults demonstrate that Rin activity is re-
quired for PKC stimulation of DAT
endocytosis.
We also visually examined DAT sur-
face levels in response to PKC activation
when DAT was coexpressed with either
wild-type or mutant Rin constructs. When
DAT was coexpressed with either vector
(data not shown) or CFP–Rin, we observed
robust DAT andRin surface expression un-
dervehicle-treatedconditions (Fig. 7).PMA
treatment for 30 min, 37°C resulted in
marked DAT redistribution to intracellular
puncta, whereas Rin dissociated from DAT
remained at the plasma membrane after
PKC activation (Fig. 7). In cells that coex-
pressed DAT and Rin mutants, DAT and
Rin were similarly expressed at the plasma
membrane under vehicle conditions (Fig.
7). However, although both wild-type Rin
and Rin S34N inhibited PKC-stimulated
DAT internalization when the global popu-
lation was examined by biochemical means (i.e., reversible biotiny-
lation; Fig. 6), we still observed a subpopulation of cells that
exhibit DAT intracellular sequestration in response to PKC
activation. In this subpopulation, and in contrast to control con-
ditions, both RinQ78L and S34N failed to dissociate fromDAT and
internalizedwithDAT into intracellular puncta after PKCactivation
(Fig. 7). The majority of intracellular Rin puncta colocalized
with DAT, although some DAT puncta were without Rin co-
localization. These results suggest that the ability of Rin to
dissociate from DAT after PKC activation is dependent on its
ability to exchange guanyl nucleotide.
We further tested whether Rin was required for PKC-
mediatedDAT trafficking, using shRNAs targeted against human
RinmRNA to knockdown cellular Rin levels. Three shRNAswere
tested for their ability to reduce cellular Rin levels in HEK293
cells. Of these, hRin228 significantly reduced Rin levels down to
68.6  12.6% of that observed in vector-transfected cells,
whereas a scrambled shRNA had no effect on Rin levels (Fig. 8B,
inset). Using these Rin-directed shRNAs, we first asked whether
Rin was required for PKC-induced DAT sequestration in the
human neuroblastoma cell line SK-N-MC. This line was chosen
because it expresses the dopamine biosynthetic enzyme tyrosine
Figure 8. Rin is required for PKC-mediated DAT sequestration. hRin knockdown and antibody internalization assay. A, hRin
knockdown. hRin-directed shRNAswere screened in HEK293 cells, 72 h after transfection. Top, Representative immunoblot show-
ing Rin levels in vector-transfected, scrambled shRNA-transfected (scr), and hRin228-transfected cells, with actin probed as a
loading control. Bottom, Averaged data. Data are expressed as percentage Rin levels compared with vector-transfected cells
(normalized to actin loading control). *p 0.05, significantly different from vector control (one-way ANOVAwith Dunnett’s post
hoc analysis; n 5). B, C, Antibody internalization assay. SK-N-MC cells cotransfected with EL2–HA–DAT and the indicated
constructs were assayed 72 h after transfection. Cells were labeled with HA antibody, and DAT internalization was assessed for 15
min, 37°C in the presence of 1M PMA as described in Materials and Methods. Cells expressing shRNA constructs were identified
by GFP coexpression. Optical z-stacks were collected and deconvolved as described in Materials and Methods. B, Averaged data.
Data are expressed as percentage SEM cells exhibiting PMA-induced intracellular DAT puncta for each of the indicated trans-
fection conditions. *p 0.05, significantly different from vector-transfected control (one-way ANOVA with Dunnett’s multiple
comparison test; n 3). C, Representative images. Planes through the cell center are shown for two cells per condition and are
representative of 30–34 cells imaged per condition over three independent experiments.
13766 • J. Neurosci., September 28, 2011 • 31(39):13758–13770 Navaroli et al. • Dopamine Transporter and Rin GTPase
hydroxylase (Z.H.S., M.J.K., and H.E.M., unpublished data) and
is compatible with commercially available human-targeted shR-
NAs.We coexpressed DAT encoding an extracellular HA epitope
tag in the second extracellular loop with control or Rin-directed
shRNA vectors and assessed PMA-induced DAT endocytosis by
labeling surface DAT with anti-HA antibody. In cells cotrans-
fected with DAT and GFP-expressing vector, treatment with 1
M PMA treatment, 15 min, 37°C resulted in robust DAT intra-
cellular puncta in 79.8 2.9%of cells (Fig. 8). CoexpressingDAT
with scrambled shRNAhadno significant effect on the number of
cells exhibiting PMA-induced DAT internalization (73.0 
11.0% of cells). In contrast, significantly fewer cells exhibited
PMA-induced DAT internalization when coexpressed with
hRin228 (37.2  8.9% cells; p  0.05, one-way ANOVA with
Dunnett’s post hoc analysis). Rin knockdown effects on DAT in-
ternalization were not attributable to global perturbation of the
endocytic machinery, because TfR endocytosis was identical in
vector- versus hRin228-transfected cells, as assessed by Alexa
Fluor 594–transferrin uptake (data not shown). These results
demonstrate that Rin is absolutely essential for PKC-induced
DAT sequestration.
Given that Rin is required for PKC-induced DAT sequestra-
tion, we used the hRin228 shRNA to ask whether Rin was re-
quired for PKC-mediated DAT functional downregulation. We
measured robust [3H]DA uptake in cells cotransfected with DAT
and vector, and PKC activation significantly decreased DA up-
take to 42.6 11.1% of vehicle-treated cells (p 0.03, Student’s
t test; n 4; Fig. 9). In contrast, PKC activation had no significant
effect onDAuptake in cells cotransfected withDAT and hRin228
(106.3 13.7% of vehicle-treated cells; p 0.72, Student’s t test;
n 4; Fig. 9), consistent with the inability of DAT to sequester in
a Rin-depleted environment.
Discussion
In the current study, we sought to identify proteins that interacted
withDAT residues 587–596 andwere central to PKC-inducedDAT
sequestration.Using thehSOSrescueyeast two-hybridapproach,we
determined that theneuronalGTPaseRin (Rit2) interactswithDAT
residues 587–596 (FREKLAYAIA) and that Rin is absolutely re-
quired for PKC-induced DAT sequestration. Rin, also known as
Rit2, is a member of the Rit subfamily of Ras-like small GTPases,
which also includes theDrosophila homolog RIC (Wes et al., 1996).
These GTPases are highly conserved and are distinguished from
other Ras-like GTPases in their lack of a C-terminal CaaX box for
prenylation. Recent evidence suggests that a polybasic charged do-
main conserved at theirC termini facilitates their plasmamembrane
association (Heoet al., 2006).WhereasRit is ubiquitously expressed,
Rin expression is reported to be limited to neurons (Lee et al., 1996),
and a recent report suggests that Rin expression is particularly en-
riched in dopaminergic neurons (Zhou et al., 2011). A recent study
also revealed that Rin exhibits significant copy number variation in
schizophrenic patient populations (Glessner et al., 2010) and that a
5.3 Mb deletion encompassing the Rin gene on chromosome
18q12.3 is present in two patients with profound speech delay
(Bouquillon et al., 2011). Together, these results suggest that Rin
may play a central role in the pathophysiology of neuropsychiatric
disorders.
What is known about the role of Rin in intracellular signaling,
and how might that shed light onto downstream pathways that
converge on DAT? Rin activates atypical PKC via interactions
with the Par6/cdc42 complex (Hoshino and Nakamura, 2003;
Hoshino et al., 2005) and a recent screen for endocytic determi-
nants in Caenorhabditis elegans revealed that the Par6/cdc42
complex is absolutely required for transferrin receptor endocyto-
sis, as well as forMHCI endocytic recycling (Balklava et al., 2007).
Additionally, the Par6/cdc42/aPKC complex is required for
E-cadherin endocytosis inDrosophila (Leibfried et al., 2008). Our
results linking Rin to regulated DAT internalization raise the
possibility that Rin may be an upstream signaling step in Par6/
cdc42-dependent endocytosis. Rin also reportedly binds to and
activates calmodulin (Lee et al., 1996). Given that CaMKII inter-
acts with the DAT C terminus and is essential for amphetamine-
mediated DA efflux through DAT (Fog et al., 2006), it is possible
that Rinmay serve as ameans to activateDAT-boundCaMKII via
calmodulin activation. Rin is also required for nerve growth fac-
tor (NGF)-stimulated neurite extension (Spencer et al., 2002a,b;
Lein et al., 2007) and p38 MAP kinase activation in response to
NGF signaling (Shi et al., 2005). Several reports link the MAP
kinase signaling pathway to DAT trafficking (Moro´n et al., 2003;
Bolan et al., 2007; Zapata et al., 2007; Mortensen et al., 2008),
potentially implicating Rin in this process as well.
We detected Rin protein expression in striatal tissue and sev-
eral dopaminergic cell lines, including SK-N-MC and PC12 (Fig.
1A). In addition, we detected Rin in non-neuronal tissues and
cell lines (data not shown), whereas previous studies reported
that Rin mRNA expression was limited to neuronal tissues as
determined byNorthern blot andRT-PCR approaches (Lee et al.,
1996). This inconsistency is not attributable to lack of specificity
of the Rin antibody, because it did not cross-react with GFP–Rit
(data not shown). Moreover, we detected both Rit and Rin
mRNA signals by RT-PCR in primary mouse embryonic kidney,
PC12, and HeLa cells, as well as in whole brain and substantia
nigra (data not shown). Thus, the apparent discrepancy between
our results and previous reportsmay reflect a lack in sensitivity in
the available approaches used at the time the previous studies
were performed. Alternatively, Rin may be ectopically expressed
in transformed cell lines.
We observed DAT/Rin associations via coimmunoprecipita-
tion in rat striatal tissue (Fig. 1) and PC12 cells (Figs. 1, 5). Ad-
ditionally, colocalization studies revealed that the DAT/Rin
interaction occurs at the plasmamembrane in PC12 andHEK293
cell lines (Figs. 2, 3, 6). We also wanted to determine whether
DAT and Rin colocalize in native dopaminergic neurons. The
commercially available Rin monoclonal antibody does not rec-
ognize Rin in situ, and our attempts at raising Rin-specific anti-
sera were not successful, thwarting our ability to examine the
DAT/Rin interaction in native preparations. As an alternative, we
Figure 9. Rin is required for PKC-induced DAT functional downregulation. [ 3H]DA uptake
assays. SK-N-MC cells were cotransfected with DAT and the indicated constructs, and [ 3H]DA
uptake was assessed 72 h after transfection. Cells were treated with or without 1M PMA, 30
min, 37°C, followed by addition of [ 3H]DA as described in Materials and Methods. Averaged
data are shown and are expressed as percentage SEM uptake of vehicle-treated cells. *p
0.03, significantly different from vehicle-treated control (Student’s t test; n 4).
Navaroli et al. • Dopamine Transporter and Rin GTPase J. Neurosci., September 28, 2011 • 31(39):13758–13770 • 13767
attempted to expressCFP–Rin in primary ventralmidbrain (VM)
neurons using lentiviral infection. Despite successful generation
of high-titer lentivirus, as determine by transduction of HEK293
cells, we were unable to reproducibly and efficiently transduce
VM neurons in culture. Future studies will explore alternative
gene delivery methods to further examine the DAT/Rin interac-
tion in situ.
DAT/Rin interactions were significantly enriched in mem-
brane raft regions within the membrane (Fig. 2B–D). A recent
report indicates that DAT localizes to both lipid raft and non-raft
domains within the plasma membrane (Foster et al., 2008) and
that DAT may be differentially regulated by PKC, depending on
its microdomain localization. Moreover, Cremona et al. (2011)
recently reported that the membrane raft protein flotilin-1 is ab-
solutely required forDAT localization to lipidmicrodomains and
for PKC-stimulated DAT sequestration. Thus, DAT/Rin interac-
tions may occur in a specific lipid microdomain that facilitates
enhanced endocytosis in response to PKC activation.
We recently reported that the charged residues at hDAT posi-
tions E589 and R590 contribute to a braking mechanism that
dampens DAT endocytic rates under basal conditions but is re-
leased during PKC activation (Boudanova et al., 2008). In agree-
ment with our findings, Sorkina et al. (2009) also recently
confirmed the existence of a negative endocytic regulatorymech-
anism. Interestingly, results from that study demonstrated that
the negative endocytic regulatory mechanism requires the DAT
N terminus. The DAT N terminus is also the target of PKC-
stimulated ubiquitination, and ubiquitination is required for
PKC-mediated DAT internalization (Miranda et al., 2007). We
observed increased DAT/Rin interactions in circumstances in
which the DAT endocytic brake is released, either during PKC
activation (Fig. 5A) or when DAT residues 587–590 are mutated
(Fig. 5C,D). These results suggest that Rin plays a role in acceler-
ating DAT endocytic rates. It also raises the possibility that there
is a synergistic interaction between theDATN andC termini that
regulates the DAT endocytic rate.
A common approach to testing the role of small GTPases is the
use of dominant-negative and constitutively active mutant GT-
Pases, which are locked in the GTP-bound and GDP-bound
states, respectively, and are unable to either hydrolyze GTP (con-
stitutively active) or exchange GDP for GTP (dominant nega-
tive). Rin Q78L and S34N mutants have been described
previously to perturb Rin function in response to growth factor
stimulation (Shi et al., 2005; Andres et al., 2006). The Rin S34N
mutant inhibited PKC-mediated DAT sequestration (Fig. 6),
consistent with a requisite role for Rin in PKC regulated DAT
endocytosis. Interestingly, overexpression of wild-type Rin also
inhibited PKC-stimulated DAT endocytosis. Overexpressed GT-
Pases can have an inhibitory effect, because they can mislocalize
and potentially sequester important factors required for vesicle
trafficking (Shipitsin and Feig, 2004). Cellular imaging revealed
that both of the Rin mutants fail to dissociate from DAT during
internalization (Fig. 7). Together with our coimmunoprecipita-
tion results, these data suggest that Rin binds to the DAT C ter-
minus to promote increased DAT internalization rates and then
dissociates from DAT during guanyl nucleotide exchange. Rab
GTPases are reported to function in a similar manner, with gua-
nyl nucleotide exchange dictating Rab movement between
membrane-bound compartments (Goody et al., 2005).
Rin depletion significantly inhibited PKC-mediated DAT se-
questration (Fig. 8). However, we should note that we did see
PKC-induced DAT internalization in a population of cells with
either high DAT expression or relatively low shRNA expression
(correlated to GFP signal intensity). This is consistent with our
previous report in which we observed that PKC-mediated DAT
trafficking is highly sensitive toDAT expression levels (Loder and
Melikian, 2003), suggesting a readily saturable cellular process.
Indeed, we also observed that excessively high DAT expression
levels in HEK293 cells resulted in a loss of PKC-induced DAT
sequestration (Z.H.S. andH.E.M., unpublished results). Surpris-
ingly, Rin knockdown also abolished PKC-mediated DAT func-
tional downregulation (Fig. 9). Foster et al. (2008) recently
reported both trafficking-dependent and -independent modes of
PKC-mediated DAT downregulation, in contrast with our find-
ings. The differences in our results may be attributable to differ-
ent cell lines used (LLC-PK1 vs SK-N-MC) or may indicate that
Rin is also required for trafficking-independent forms of PKC-
mediated DAT downregulation. One possibility is that distinct
PKC isoforms may participate in trafficking-dependent and
-independent DAT regulatory mechanisms. A recent report sug-
gests that PKC plays a central role in DAT trafficking (Chen et
al., 2009). In addition, previous studies demonstrated that mul-
tiple PKC isoforms are capable of functional DAT downregula-
tion (Doolen and Zahniser, 2002). Because phorbol ester
treatment activates multiple PKC isoforms, simultaneously, we
cannot conclude whether or not specific PKC isoforms underlie
the trafficking-dependent and -independent forms of DAT
downregulation. However, future studies exploring the role of
specific PKC isoforms in Rin-mediated DAT trafficking should
be illuminating in this regard.
Recent studies have revealed a central role for biogenic amine
transporter function in neuropsychiatric disorders, including
ADHD (Mazei-Robison et al., 2008) and autism (Prasad et al.,
2009). Given the eminent role that transporters play, both as
addictive and therapeutic drug targets, as well as in the patho-
physiology of neuropsychiatric diseases, modulation of trans-
porter availability by membrane trafficking is likely to have a
significant impact on both normal and aberrant neurotransmis-
sion. The identification of Rin as a critical modulator of DAT
trafficking and as a potentially important link between DAT,
CaMKII, and MAP kinase signaling will undoubtedly shed addi-
tional light on the mechanisms governing dopamine levels and
plasticity in the brain.Moreover, these studies raise the possibility
that Rin may play a larger role in synaptic endocytic trafficking.
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